FORMAN ERIC (Secretary) purchased 16.11K shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $9.8K. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/13/2022ACC: 0001493152-22-035281
Officer· Secretary
Since Dec 2020
+16.11K
Net shares
Net buyer
$9.8K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
16.11K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+10K
Price / share
$0.60
Trade value
$6K
% of position
New position
12/9/2022
-10K→N/A
Common Stock
Indirect
Shares
+5K
Price / share
$0.63
Trade value
$3.14K
% of position
New position
12/9/2022
-5K→N/A
Common Stock
Indirect
Shares
+1.11K
Price / share
$0.63
Trade value
$700.56
% of position
New position
12/9/2022
-1.11K→N/A
Total
Net shares
+16.11K
Net value
$9.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/9/2022 | P · Purchase | +10K | $0.60 | $6K | New position | -10K | N/A |
| Common Stock Indirect | 12/9/2022 | P · Purchase | +5K | $0.63 | $3.14K | New position | -5K | N/A |
| Common Stock Indirect | 12/9/2022 | P · Purchase | +1.11K | $0.63 | $700.56 | New position | -1.11K | N/A |
| Total | +16.11K | $9.84K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares ownedN/A
Total
0.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | N/A | Direct |
| Total | 0.00 |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported